Transcend Therapeutics
Founded 2021 · 32 employees on LinkedIn · 4 known investors
Find your way into Transcend Therapeutics
Transcend Therapeutics develops rapid-acting pharmaceutical treatments for neuropsychiatric diseases, including PTSD and depression, targeting patients unresponsive to current psychiatric medications. The company is a clinical-stage biotech firm focused on neuroscience-based drug development.
Founders & leadership
Transcend Therapeutics was founded in 2021 by Blake Mandell.
BM
Blake Mandellin𝕏Co-Founder & CEOBlake Mandell is the co-founder and CEO of Transcend Therapeutics, a clinical-stage neuroscience company developing rapid-acting treatments for PTSD and other neuropsychiatric diseases. He previously worked at AlleyCorp and Pace Capital, and began his career at Boston Consulting Group.30 Under 30 2023
Investors · 4
Frequently asked questions
- What does Transcend Therapeutics do?
- Transcend Therapeutics develops rapid-acting pharmaceutical treatments for neuropsychiatric diseases, including PTSD and depression, targeting patients unresponsive to current psychiatric medications. The company is a clinical-stage biotech firm focused on neuroscience-based drug development.
- Who founded Transcend Therapeutics?
- Transcend Therapeutics was founded by Blake Mandell in 2021.
- Who are Transcend Therapeutics's investors?
- Transcend Therapeutics's investors include AlleyCorp, Alpha Wave Global, Emerald Development Managers, Alley Robotics Ventures.